top of page

CHO-K1/Human QRFP Stable Cell

Item
Cat#
Price

Stable Cell Line

SNB-G-0207A

$19,800

Compound Testing Services

CT-001

$1,850 per 384w plate

(Up To 16 cpds Dose)


Product Description


The QRFP receptor, also known as GPR103, is a G protein-coupled receptor primarily expressed in the central nervous system (e.g., hypothalamus, amygdala, hippocampus) and peripheral tissues (e.g., retina, heart, kidney, and testis). Upon activation by its ligand QRFP (an RF-amide neuropeptide), it mediates intracellular calcium mobilization and cAMP modulation via Gq and Gi/o proteins, playing key roles in regulating feeding behavior and energy homeostasis, modulating blood pressure and heart rate, influencing bone formation, and participating in nociception. This receptor has emerged as a potential drug target for obesity, metabolic syndrome, and cardiovascular diseases.

 

Screeningbio’s CHO-K1/Human QRFP cell line overexpress QRFPR receptor and is designed to detect increases in intracellular IP-1 levels in response to agonist stimulation of the receptor. Cisbio HTRF IP-1 kit can be used to detect the signal.

Product Specifications

Target Type

GPCR

Species

Human

HGNC Symbol

QRFPR

Accession Number

NM_198179 (Hs)

Parental Line

CHO-K1

Lot#

See Vial

Storage

Liquid Nitrogen


Data

CHO-K1/Human QRFP Agonist Assay. CHO-K1/Human QRFP cells were treated with the reference agonist. The assay was run based on Revvity IP-one HTRF protocol. Non-linear regression was used to plot activity changes vs. [Compound, M], and EC50 /IC50 values were determined, using GraphPad Prism software.
CHO-K1/Human QRFP Agonist Assay. CHO-K1/Human QRFP cells were treated with the reference agonist. The assay was run based on Revvity IP-one HTRF protocol. Non-linear regression was used to plot activity changes vs. [Compound, M], and EC50 /IC50 values were determined, using GraphPad Prism software.


Target Background


The QRFP receptor, also known as GPR103, is a G protein-coupled receptor primarily expressed in the central nervous system (e.g., hypothalamus, amygdala, hippocampus) and peripheral tissues (e.g., retina, heart, kidney, and testis).


Upon activation by its ligand QRFP (an RF-amide neuropeptide), it mediates intracellular calcium mobilization and cAMP modulation via Gq and Gi/o proteins, playing key roles in regulating feeding behavior and energy homeostasis, modulating blood pressure and heart rate, influencing bone formation, and participating in nociception.


This receptor has emerged as a potential drug target for obesity, metabolic syndrome, and cardiovascular diseases.

Product Documentation



Screeningbio

For research use only. All rights reserved. Not for use in diagnostic procedures, human or veterinary treatment, food, cosmetics, or household applications. ScreeningBio provides laboratory research products and R&D services to qualified research organizations. We do not sell pharmaceuticals, dietary supplements, or products intended for human consumption.

6181 Cornerstone Ct, Suite 102, San Diego, CA 92121, USA

Quick Links

Connect

  • Facebook
  • Twitter
  • LinkedIn

CHINA: 上海格宁生物

info@screeningbio.com

4th Floor, Building 24, No.1188 Lianhang Road Minhang District, Shanghai, China

bottom of page